Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The Prostate Cancer Prevention Trial: Current status and lessons learned.

I M Thompson1, M Kouril, E A Klein

  • 1Division of Urology, University of Texas Health Sciences Center at San Antonio, San Antonio, Texas, USA. thompsoni@uthscsa.edu

Urology
|April 11, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

PROfessionalism in Partnership for Education Research (PROPER) study: a novel online initiative approach to professionalism education.

BMC medical education·2026
Same author

The effect of concentrate crude protein concentration and replacing imported feed ingredients with locally grown cereals and faba bean on milk production and nitrogen utilization in grazing dairy cows.

Journal of dairy science·2026
Same author

Clival metastasis presenting with oculomotor nerve palsy in a patient with a prior history of breast cancer.

Irish medical journal·2025
Same author

The Stable Acute Vertebral (SAVe) compression fracture study.

Irish medical journal·2024
Same author

Expanded carrier screening for inherited genetic disease using exome and genome sequencing.

Journal of genetic counseling·2024
Same author

A randomized single-blinded prospective study comparing simulated daylight photodynamic therapy with natural daylight photodynamic therapy for multiple actinic keratoses.

Journal of the European Academy of Dermatology and Venereology : JEADV·2024
Same journal

"Editorial Comment on "Vaginal Estrogen Prescription is Associated with Reduced Rates of Serious Adverse Outcomes in Women of All Age Groups With Recurrent Urinary Tract Infection: An Epic Cosmos Database Analysis".

Urology·2026
Same journal

The True Oral History of Buccal Mucosal Grafts for Male Urethral Stricture Repair.

Urology·2026
Same journal

Preventing Postpartum Pelvic Floor Dysfunction: Clinical Evidence and Policy Gaps in U.S. Coverage of Pelvic Floor Muscle Therapy.

Urology·2026
Same journal

Editorial Comment on "Through the Eyes of the Applicant: A Qualitative Study of the Urology Residency Match".

Urology·2026
Same journal

Editorial Comment on "A Histopathologic Assessment of Prostate Ductal Anatomy in Relation to Micro-Ultrasound".

Urology·2026
Same journal

Same-Day Discharge Following Multiport Robot-Assisted Simple Prostatectomy: A Prospective Feasibility Study of Outcomes, Costs, and Post-Discharge Healthcare Utilization.

Urology·2026
See all related articles

US men readily participate in large prostate cancer prevention trials. Key factors for success include robust data management, staff training, and adaptable study designs for future chemoprevention research.

Area of Science:

  • Oncology
  • Clinical Trials
  • Preventive Medicine

Background:

  • The Prostate Cancer Prevention Trial was the first large-scale, phase 3 chemoprevention study for prostate cancer in the United States.
  • This trial generated significant data crucial for designing future cancer prevention studies in men.

Purpose of the Study:

  • To review the implementation experience of the Prostate Cancer Prevention Trial.
  • To identify key lessons learned for conducting future large-scale, randomized cancer chemoprevention trials.

Main Methods:

  • Review of implementation experiences from the Prostate Cancer Prevention Trial.
  • Analysis of factors contributing to trial success and challenges encountered.

Main Results:

Related Experiment Videos

  • US men are willing to enroll in prevention trials, viewing them as "men's health trials."
  • Trial success depends on participant characteristics (educated, healthy), effective data management, institutional coordination, and staff training.
  • Adaptability in study design is necessary due to evolving clinical practices during long-term trials.

Conclusions:

  • Large-scale, randomized chemoprevention trials are feasible in the US with proper design, data management, and flexible staffing.
  • The insights gained will facilitate future advancements in prostate cancer chemoprevention strategies.